scholarly journals Life-threatening complications of adult-onset Still’s disease

2014 ◽  
Vol 33 (3) ◽  
pp. 305-314 ◽  
Author(s):  
Petros Efthimiou ◽  
Sabeeda Kadavath ◽  
Bella Mehta
2021 ◽  
Vol 23 (1) ◽  
Author(s):  
Anaïs Wahbi ◽  
Benoît Tessoulin ◽  
Cédric Bretonnière ◽  
Julien Boileau ◽  
Dorothée Carpentier ◽  
...  

Abstract Objectives Adult-onset Still’s disease (AOSD) is a rare systemic inflammatory disorder. Diagnosing AOSD can be challenging, as disease presentation and clinical course are highly heterogeneous. For unclear reasons, a few patients develop life-threatening complications. Our objective was to determine whether these cases resulted from therapeutic delay or could represent a peculiar AOSD subset. Methods We conducted a multicentre retrospective study of 20 AOSD patients with organ failure requiring intensive care unit admission and 41 control AOSD patients without organ failure. Clinico-biological data at hospital admission were explored using supervised analyses and unsupervised dimension reduction analysis (factor analysis of mixed data, FAMD). Results Disease duration before admission was shorter in patients with life-threatening AOSD (median, 10 vs 20 days, p = 0.007). Disease duration before AOSD therapy initiation also tended to be shorter (median, 24 vs 32 days, p = 0.068). Despite this shorter disease duration, FAMD, hierarchical clustering and univariate analyses showed that these patients exhibited distinctive characteristics at first presentation, including younger age; higher frequency of splenomegaly, liver, cardiac and/or lung involvement; less frequent arthralgia; and higher ferritin level. In multivariate analysis, 3 parameters predicted life-threatening complications: lack of arthralgia, younger age and shorter time between fever onset and hospitalisation. Conclusion This study suggests that life-threatening complications of AOSD occur very early, in a peculiar subset, which we propose to name catastrophic adult-onset Still’s disease (CAOSD). Its exact burden may be underestimated and remains to be clarified through large multicentre cohorts. Further studies are needed to identify red flags and define the optimal therapeutic strategy.


2019 ◽  
Vol 2019 ◽  
pp. 1-3
Author(s):  
Kami M. Hu ◽  
Adam C. Richardson ◽  
Kelly M. Blosser ◽  
Semhar Z. Tewelde

A 34-year-old man with recent treatment and resolution of community-acquired pneumonia presents to the emergency department with protracted fever, rash, and sore throat. Sustained fever and greater than two-fold increase in leukocytosis despite appropriate antibiotic therapy prompted hospital admission for infectious disease and rheumatologic evaluations which ultimately revealed adult-onset Still’s disease, a rare autoinflammatory disorder with potentially life-threatening complications.


2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 954.2-955
Author(s):  
I. DI Cola ◽  
F. Bruno ◽  
O. Berardicurti ◽  
R. Monti ◽  
A. Conforti ◽  
...  

Background:Adult-onset Still’s disease (AOSD) is a rare systemic inflammatory disorder usually affecting young adults, burdened by life-threatening complications, mainly macrophage activation syndrome (MAS), a secondary form of hemophagocytic lymphohistiocytosis [1]. In this context, the importance of an accurate assessment of AOSD is suggested to promptly recognise the multivisceral involvement of the disease which is associated with life-threatening complications. The assessment of the most aggressive subsets of the disease could guide the clinicians when to apply additional resources but avoiding unnecessary expenditures in patients with a less severe clinical picture.Objectives:In this study, we aimed at describing the multivisceral involvement of the disease to retrieve imaging-based differences in AOSD patients with and without MAS.Methods:The present evaluation has been designed as a cross-sectional study to descriptively compare the multivisceral involvement in AOSD patients with and without MAS. Patients admitted to our Institution, who underwent a total body CT scan, were selected from our historical cohort and assessed. Clinical and CT scan characteristics of AOSD patients with and without MAS were compared. Clinical and CT scan characteristics of AOSD patients with and without MAS were analysed by parametric or non-parametric t tests for all continuous variables, and chi squared test was used for categorical ones, as appropriate. Furthermore, possible correlations among radiological outcomes with laboratory markers and systemic score were estimated by using a point-biserial coefficient correlation.Results:This study evaluated 39 AOSD patients (men 64.1%), mean age of 48.8±16.6 years). Out of those, 14 patients (35.9%) were complicated by MAS. These patients showed higher values of ferritin [AOSD: 770.0 (1306.5) ng/mL vs MAS: 2926.3 (4918.5) ng/mL p=0.003] and systemic score (AOSD: 4.6±1.4 vs MAS: 6.9±1.7, p<0.0001). AOSD patients with MAS presented a higher prevalence of lung disease than others (AOSD: 56.0% vs MAS 85.7% p=0.048). Lung disease correlated with the systemic score (coefficient 0.491, p=0.003). AOSD patients with MAS were more frequently characterised by hepatomegaly (AOSD: 12.0% vs MAS: 50.0% p=0.019) and splenomegaly (AOSD: 16.0% vs MAS 50.0% p=0.033), respectively, than others. Hepatomegaly correlated with CRP (coefficient 0.421, p=0.016), ferritin (coefficient 0.397, p=0.020), and systemic score (coefficient 0.391, p=0.022). Furthermore, the presence of splenomegaly correlated with the systemic score (coefficient 0.439, p=0.009). CT scan features of abdominal effusions were more frequently observed in AOSD patients with MAS than those without this complication (AOSD: 12.0% vs 57.1% p=0.007). Finally, a higher percentage of AOSD patients with MAS showed a significant lymph node enlargement, either mediastinal or abdominal, than others on CT scan (AOSD: 36.0% vs MAS 71.4% p=0.048). The presence of lymphadenomegaly correlated with the systemic score (coefficient 0.368, p=0.032).Conclusion:Our findings showed a higher prevalence of multiorgan involvement in AOSD patients with MAS, suggesting imaging-based differences, although other studies are needed to fully assess this issue. Pulmonary disease, hepatomegaly, splenomegaly, lymph nodes enlargement, and abdominal effusions were associated with these more aggressive patients.References:[1]Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset Still’s disease. J Autoimmun. 2018 Sep;93:24-36.Disclosure of Interests:None declared


2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1930.1-1930
Author(s):  
G. Zhang ◽  
W. Liu ◽  
T. Xu ◽  
X. Zhang

Background:Adult-onset still’s disease (AOSD) is a systemic inflammatory condition characterized by fevers, polyarthritis, skin rashes and increased leukocyte and neutrophil counts [1]. Sometimes life-threatening complications such as macrophage activation syndrome (MAS), disseminated intravascular coagulopathy (DIC) can be occurred without response to glucocorticoid and disease-modifying antirheumatic drugs (DMARDs).Objectives:To describe an AOSD patient with life-threatening interstitial lung disease (ILD) and MAS response to tocilizumab.Methods:This is a case report at our medical practice.Results:A 43-year-old man was hospitalized for a 2-week history of fever accompanying skin rashes, polyarthritis, sore throat, leukocytosis (the maximum leukocyte count 37.25×109/L with 89.9% neutrophils), elevated levels of C-reactive protein (190.9mg/L) and ferritin level was very high (>15000ng/ml), Several antibiotics were consequently used, but fever was on going. Chest CT displayed diffuse interstitial lung disease. Infectious diseases and lymphoma were excluded and AOSD with ILD was diagnosed. However, MAS occurred the 20 days later after the pulse of intravenous MP (MP 500mg×3days) following MP 40 mg/day, which cannot stop the situation deteriorating. The minimum total white blood cells, hemoglobin and platelets went down to 0.25×109/l, 53g/l and 18×109/l. Finally, tocilizumab rescued this patient from desperation.Conclusion:Tocilizumab was effective in AOSD with life-threatening ILD and MAS.References:[1]E. Feist, S. Mitrovic, and B. Fautrel, Mechanisms, biomarkers and targets for adult-onset Still’s disease. Nat Rev Rheumatol 14 (2018) 603-618.Disclosure of Interests:None declared


2020 ◽  
pp. 117-123
Author(s):  
Muhammad Sohaib Asghar ◽  
Abubakar Tauseef ◽  
Warda Fatmi ◽  
Narmin Khan ◽  
Maryam Zafar ◽  
...  

Haemophagocytic lymphohistiocytosis (HLH) is a rare but potentially aggressive and life-threatening syndrome of overactive histiocytes and lymphocytes that commonly affects infants; it is also observed in children and adults of all ages. The disease is differentiated into either primary or secondary causes. Primary HLH tends to be of genetic origin, while secondary HLH results from either infection, autoimmune disorders, or malignancies. Secondary HLH is most commonly associated with viral infections in immunocompromised patients. This paper presents a case of HLH in a tertiary care hospital, associated with adult-onset Still’s disease, diagnosed on both biochemical criteria and histopathologic examination of bone marrow smear.


2018 ◽  
Vol 4 (2) ◽  
pp. 101-105 ◽  
Author(s):  
Veronica Calborean ◽  
Victor Gheorman ◽  
Cristian Constantin ◽  
Octavian Istrătoaie

Abstract A 56-year-old man presented to the emergency department with pain, swelling, and restricted mobility of the left lower limb and shortness of breath on exertion in the previous 3 days. Seven months prior to this presentation, he had been diagnosed with adult-onset Still’s disease based on the Yamuguchi criteria, after excluding the presence of any other disease. The patient had been treated with prednisolone and methotrexate. Subsequent investigations revealed that he developed bilateral deep venous thrombosis and bilateral pulmonary emboli. This case emphasizes that adult-onset Still’s disease can be a rare but life-threatening cause of venous thromboembolism.


2018 ◽  
Vol 56 (4) ◽  
pp. 506-514
Author(s):  
V. V. Lebedeva ◽  
Yu. V. Muravyev

The review gives an update on adult-onset Still’s disease: on its causes, the specific features of its pathogenesis, diagnosis, clinical presentations (with identification of subtypes), and treatment with consideration for the nature of the course of the disease and life-threatening complications.


Sign in / Sign up

Export Citation Format

Share Document